Epizootic rabbit enteropathy (ERE), a disease of still unknown aetiology has emerged worldwide in the past decade, as the most important health problem in rabbit industry. Despite its still obscure pathogenesis, ERE can be effectively prevented by strategic oral bacitracin therapy. The authors tested the efficacy of a bacitracin and oxitetracycline combination in the prevention of ERE on 21 commercial Hungarian rabbit farms in the process of licence renewal and claim extension of Trierra A.U.V. medication. Their results clearly showed the benefit of this medication in the prevention of ERE, as it has been reported previously from other countries, as well. Based on historical data, average fattening mortality was about 22% in the untreated groups, which decreased dramatically to about 5% in the treated groups.
|Translated title of the contribution||Prevention of losses due to epizootic rabbit enteropathy by product containing bacitracin and oxitetracycline in Hungarian commercial rabbit flocks|
|Number of pages||6|
|Journal||Magyar Allatorvosok Lapja|
|Publication status||Published - Jun 1 2010|
ASJC Scopus subject areas